Q2 2025 – Talk Bio

Actionable Insights Powered by AI

AstraZeneca Beats Q2 Estimates on Strong Cancer Drug Sales

1 week ago talkbio0Tagged AstraZeneca, Cancer Drug Sales, Enhertu, financial results, Imfinzi, oncology portfolio, Q2 2025, Tagrisso

AstraZeneca; Q2 2025; cancer drug sales; oncology portfolio; Tagrisso; Imfinzi; Enhertu; financial results

Merck Announces $3 Billion Cost-Cutting and Restructuring Plan

1 week ago talkbio0Tagged Drug Industry, estate, Financial cost, Keytruda, Merck, Q2 2025, restructuring, Transection (procedure)

Merck; cost cutting; restructuring; job cuts; real estate reduction; Keytruda; pharmaceutical industry; Q2 2025 financials